VALUE PROPOSITIONS
What is Liquid Biopsy?
A liquid biopsy is a simple and non-invasive alternative to surgical biopsies which enable doctors to obtain information about a tumor through a simple blood draw. The information obtained from the blood draw including circulating tumor cells can provide valuable information for cancer patient diagnosis and prognosis.
Why Liquid Biopsy?
Cancer is a genetic disease characterized by high heterogeneity within a tumor. Therefore, the current gold standard of cancer diagnostics using a primary tumor biopsy may not be reflective of the disease condition. In addition, the surgical procedure is highly invasive and require patient tumor accessibility which may not be feasible in all patients.
Liquid biopsy enables the capture of cancer heterogeneity in a patient, providing more holistic information about the disease. This potentially enables the real-time monitoring of cancer dynamics which can be particularly useful for cancer patient status monitoring and treatment response through periodic patient blood draws.
Liquid Biopsy Methods: What are the differences between Circulating Tumour Cells (CTC) and Circulating Tumour DNA (ctDNA)?
The ClearCell® Solution
Fully automated and entirely label-free, Biolidics' ClearCell® FX1 System, with the patented microfluidic biochip, CTChip® FR1, the ClearCell® FX1 System achieves label-free CTC enrichment that better addresses the dynamic and complex nature of cancer. It even provides the potential for serial real-time treatment monitoring.
